Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
31.2K
-
Shares change
-
-3.43K
-
Total reported value, excl. options
-
$265K
-
Value change
-
-$80.2K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$8.51
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q4 2023
3 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q4 2023.
Replimune Group, Inc. - COMMON STOCK (REPL) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.2K shares
of 78.4M outstanding shares and own 0.04% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (9.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.85M shares), STATE STREET CORP (5.11M shares), FCPM III SERVICES B.V. (4.87M shares), BlackRock Inc. (4.54M shares), MORGAN STANLEY (4.45M shares), Redmile Group, LLC (3.87M shares), Omega Fund Management, LLC (3M shares), VANGUARD GROUP INC (2.74M shares), and GOLDMAN SACHS GROUP INC (2.24M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.